TrovaGene Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,810.90
14,325.50
27,471.10
39,203.70
24,906.70
16,461.20
Depreciation, Depletion & Amortization
130.50
234.80
378.70
1,069.50
1,247.60
859.50
Other Funds
516.00
-
-
-
-
2,149.20
Funds from Operations
8,369.60
13,165.30
21,981.10
32,128.30
20,155.20
13,452.50
Changes in Working Capital
1,052.30
437.90
137.90
1,088.40
3,125.80
253.40
Net Operating Cash Flow
7,317.20
12,727.40
22,119.00
31,039.90
23,281.10
13,199
Capital Expenditures
649.30
363.30
2,241.10
823.50
101.10
Sale of Fixed Assets & Businesses
-
63.50
7.60
-
1.50
Purchase/Sale of Investments
-
-
-
24,010.20
24,061.80
Net Investing Cash Flow
649.30
299.80
2,233.50
24,833.60
23,962.20
Issuance/Reduction of Debt, Net
-
14,484.00
1,086.10
351.00
17,239.20
Net Financing Cash Flow
22,983.70
14,484.00
64,551.70
2,301.40
6,378.10
Net Change in Cash
15,017.20
1,456.90
40,199.20
53,578.00
5,689.30
Free Cash Flow
7,966.50
13,090.70
24,360.10
31,863.30
23,382.20
Change in Capital Stock
22,467.70
-
63,465.70
2,652.40
10,861.10
Exchange Rate Effect
-
-
-
5.80
7.60
About TrovaGene
View Profile
